Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, ...

Plasma fractionation – Our clinical research activities make products available to patients worldwide and identify novel therapeutic uses for plasma proteins. As a leading manufacturer and ...

The collaboration with Kedrion enabled the further examination of Ceruloplasmin protein produced from an industrial plasma processing waste fraction. What is the role of a Foundation such as TLS ...